ALSPW Spineway SAS

INTERNATIONAL MASTERCLASS

INTERNATIONAL MASTERCLASS

   

Spineway organizes an international masterclass

with expert spine surgeons

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its Spineway Academy department, with the support of 1

The event featured some 20 scientific papers and interactive round-table discussions led by opinion-leading surgeons who discussed their respective working practices and philosophies, and their experience with the prostheses used around the world and available in the various markets.

Over 60 French and international participants (USA, Mexico, Germany, UK, Spain, Luxembourg, Sweden, Switzerland, Thailand, India, Hong Kong, Australia) shared their experiences of disc replacement with cervical and lumbar disc prostheses.

Training at the Institut du Fer Moulin

On Monday September 11, Spineway Academy also held a training session on the implantation of its ESP prostheses at the .

It gave surgeons from Germany, Thailand and Malaysia the chance to train, practice and work under the guidance of expert surgeons in disc arthroplasty, and in that way to consolidate their practice. Spineway would like to extend particular thanks to the German surgeons who attended the event, and notes that Germany is a strategic market for its premium products such as ESP prostheses.

A department dedicated to scientific exchange and training for surgeons

The Spineway Academy department promotes scientific exchange and has the following main objectives:

  1. Strengthen scientific relations: by sharing experience between peers, encourage the transmission of information so that surgeons can develop their practice (diagnosis, indications, surgical procedure, evaluation and follow-up of results, publications) with the aim of improving post-operative outcomes/satisfaction for their patients.



  2. Organize training sessions: provide training in the use of instruments to support surgeons during their surgical procedures and anticipate the various surgical scenarios they may face so as to secure the procedure for the benefit of the patient.



Since the beginning of the year, the Spineway Academy has trained more than 220 French and international surgeons. These events help promote the visibility of Spineway products and serve to strengthen the Group’s reputation across its various geographies.

Next events:

September 19, 2023 – H1 2023 results

October 4 to 6, 2023 – Eurospine meeting in Frankfurt

October 12, 2023 – Q1 2023 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)

Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.

Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).

ISIN: FR001400BVK2 - ALSPW        

Contacts:





SPINEWAY



Shareholder-services line



Available Tuesday through Thursday



+33 (0)806 706 060




Eligible PEA / PME





ALSPW





Euronext Growth





AELIUM



Finance & Communication



Investor relations



Solène Kennis






1 A learned society whose purpose is to organize scientific conferences, publish scientific works, evaluate clinical results and provide medical training.

 

Attachment



EN
14/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE

Spineway : H1 2025 results - Continued improvement in results and fina...

Spineway : H1 2025 results - Continued improvement in results and financial position Press release         Ecully, July 30, 2025 – 7 p.m.   SPINEWAY H1 2025 results  Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of eurosConsolidated financial statements – UnauditedH1 2025H1 2024Revenue5,5736,535Cost of sales(1,702)(2,059)Gross margin% of revenue3,87069%4,47668%Net operating expensesOf which general operating costs(5,068)(2,086)(5,246)(2,232)Of which personnel expenses(2,374)(2,685)Operating income/(loss)(1,197)(770)Fina...

 PRESS RELEASE

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration de...

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration des résultats et de la situation financière Communiqué de presse        Ecully, le 30 juillet 2025 –19h SPINEWAY Résultats semestriels 2025 Poursuite de l’amélioration des résultats et de la situation financièreObjectif de croissance confirmé pour l’année 2025 En milliers d'eurosComptes consolidés – Non auditésS1 2025S1 2024Chiffre d'affaires5 5736 535Coût des ventes- 1 702- 2 059Marge brute% du CA3 87069%4 47668%Coûts nets d’exploitationDont coûts de fonctionnement- 5 068- 2 086- 5 246- 2 232Dont charges de personnel-...

 PRESS RELEASE

Spineway : GMED approval for new production line dedicated to ESP pros...

Spineway : GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses Press release         Ecully, July 3, 2025 – 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral di...

 PRESS RELEASE

SPINEWAY : Approbation du GMED pour la nouvelle ligne de production dé...

SPINEWAY : Approbation du GMED pour la nouvelle ligne de production dédiée aux prothèses ESP - 1ère production de prothèses de disque intervertébral LP-ESP Communiqué de presse          Ecully, le 3 juillet 2025 – 18h30 SPINEWAY Approbation du GMED pour la nouvelle ligne de production dédiée aux prothèses ESP 1ère production de prothèses de disque intervertébral LP-ESP Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), annonce que sa filiale Spine Innovations a reçu la validation du (Organisme notifié français) ...

 PRESS RELEASE

Spineway : Minutes of the General Meeting of June 4, 2025

Spineway : Minutes of the General Meeting of June 4, 2025 Press release         Ecully, June 6, 2025 – 6.00 p.m.   SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Wednesday, June 4, 2025 at 2:00 p.m at the company’s registered office, 7 allée Moulin Berger in Ecully (69). The defaulting shareholders were represented by SELARL TULIER POLGE ALIREZAI, as ad hoc representative appointed by Order of the President of the Lyon Commercial Court dated April 30, 2025. The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch